The reported rate of EGFR T790M of 32% is on the lower end of that reported in the literature based on tumor tissue testing38–40, possibly reflecting the small sample size or the high proportion of Japanese patients in this cohort (the T790M mutation rate in Japanese patients may be lower than in Caucasians)41. Here, EGFR is linked to neoplasm.